Maha Katabi - General Partner @ Sofinnova Investments

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

93,895

Primary Job Title General Partner
Primary Organization
Sofinnova Investments

Location Montréal, Quebec, Canada
Gender Female

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Maha Katabi is based out of Montreal, Quebec and is the Board of Director of ARTBIO and also General Partner of Sofinnova Investments. Maha previoulsy worked at Sofinnova Investments as a Partner. Maha Katabi attended McGill University. Maha Katabi has been received Chartered Financial Analyst (CFA) certificate.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Coultreon Biopharma	Sofinnova Investments	Yes	Series A - Coultreon Biopharma	obfuscated obfuscation
obfuscated obfuscation	Star Therapeutics	Sofinnova Investments	—	Series D - Star Therapeutics	obfuscated obfuscation
obfuscated obfuscation	ARTBIO	Sofinnova Investments	Yes	Series B - ARTBIO	obfuscated obfuscation
obfuscated obfuscation	Marea Therapeutics	Sofinnova Investments	Yes	Series B - Marea Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Star Therapeutics	Sofinnova Investments	Yes	Series C - Star Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Quanta Therapeutics	Sofinnova Investments	—	Series D - Quanta Therapeutics	obfuscated obfuscation
obfuscated obfuscation	RayzeBio	Sofinnova Investments	Yes	Series D - RayzeBio	obfuscated obfuscation
obfuscated obfuscation	Gyroscope Therapeutics	Sofinnova Investments	—	Series C - Gyroscope Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Vera Therapeutics	Sofinnova Investments	—	Series C - Vera Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Aerovate Therapeutics	Sofinnova Investments	Yes	Series A - Aerovate Therapeutics	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Maha Katabi

is the

General Partner

Sofinnova Investments

. Additionally,

Maha Katabi

has had

past jobs including

Partner

Sofinnova Investments

Sofinnova Investments General PartnerApr 2020

Organization Name	Title At Company	Start Date	End Date
Sofinnova Investments	Partner	Apr 2019	Mar 2020
Sectoral Asset Management	Partner	2008	Jan 2018

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Maha Katabi

holds

board and advisor roles including

Board of Director

ARTBIO

Board Member

Marea Therapeutics

, and

Board Member

Vera Therapeutics

ARTBIO Board of DirectorAug 7, 2025
Marea Therapeutics Board MemberJun 2024
Vera Therapeutics Board MemberJan 2021

Organization Name	Title At Company	Start Date	End Date
Aerovate Therapeutics	Board Member	Aug 6, 2020	Sep 2024
RayzeBio	Board Member	Aug 2022	Sep 2024
Gyroscope Therapeutics	Board Member	Mar 2021	Mar 2022
Apellis Pharmaceuticals	Board of Director	Jul 2017	Nov 2017

Related Hubs

Hub Name	CB Rank (Hub)
Sofinnova Partners Alumni Founded Companies	96,318
Investors with Funds Raised in 2003	77,442
Post IPO Investors Venture Capital Investors	19,695
Burr, Egan, Deleage & Co Alumni Founded Companies	75,272
Investors with Funds Raised in 2011	43,133

Education

Maha Katabi

studied at

McGill University

McGill University Doctor of PhilosophyPharmacology and Therapeutics19941999